2025-04-24 22:59:24
Latest Post
Prime Securities Ltd Q4 FY2025 net profit at Rs. 96 lakhs
Macrotech Developers Ltd consolidated Q4FY25 PAT at Rs. 921.7 crores
Accelya Solutions' Consolidated Income for Q3 at Rs. 1,367.55 Million
Insolation Energy Limited invests in rights issue of Insolation Green Energy Pvt Ltd
Minor fire incident in BHEL Bhopal
Stock Report
Emmessar Biotech and Nutrition Ltd Q4FY25 loss at Rs. 6.86 lakhs
Posted On : 2025-04-24 19:54:31( TIMEZONE : IST )
EMMESSAR BIOTECH & NUTRITION LTD. has reported Standalone financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 0.7036 crores during the period ended March 31, 2025 as compared to Rs. 0.5298 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. -0.0686 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 0.0172 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. -0.16 for the period ended March 31, 2025 as compared to Rs. 0.03 for the period ended December 31, 2024.
| Financials | Q4 FY2025 | Q3 FY2025 | % Change |
| Total Income | ₹ 0.7036 crs | ₹0.5298 crs |  32.80% |
| Net Profit | ₹-0.0686 crs | ₹0.0172 crs |  -498.84% |
| EPS | ₹-0.16 | ₹0.03 | -633.33% |
Financial Results (Q4 FY2025) - YoY Comparison
The company has reported total income of Rs. 0.7036 crores during the period ended March 31, 2025 as compared to Rs.0.5588 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.-0.0686 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.0.27 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.-0.16 for the period ended March 31, 2025 as compared to Rs.0.52 for the period ended March 31, 2024.
| Financials | Q4 FY2025 | Q4 FY2024 | % Change |
| Total Income | ₹ 0.7036 crs | ₹0.5588 crs | 25.91% |
| Net Profit | ₹-0.0686 crs | ₹0.27 crs | -125.41% |
| EPS | ₹-0.16 | ₹0.52 | -130.77% |
Financial Results (Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.2.6196 crores during the Financial Year ended March 31, 2025 as compared to Rs.2.5473 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.0.3161 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.0.6511 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.0.61 for the Financial Year ended March 31, 2025 as compared to Rs.1.28 for the Financial Year ended March 31, 2024.
| Financials | Year Ended FY2025 | Year Ended FY2024 | % Change |
| Total Income | ₹2.6196 crs | ₹2.5473 crs | 2.84% |
| Net Profit | ₹0.3161 crs | ₹0.6511 crs | -51.45% |
| EPS | ₹0.61 | ₹1.28 | -52.34% |
Shares of EMMESSAR BIOTECH & NUTRITION LTD. was last trading in BSE at Rs. 40.09 as compared to the previous close of Rs. 36.38. The total number of shares traded during the day was 9995 in over 89 trades.
The stock hit an intraday high of Rs. 40.90 and intraday low of 36.00. The net turnover during the day was Rs. 386255.00.
